Tolterodine

CHEMBL1382 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

325.5 g/mol

LogP

5.6

Phase

4

This medication is used to treat overactive bladder, a condition characterized by frequent, urgent, and sometimes uncontrollable urination. It works by relaxing the bladder muscle by blocking muscarinic receptors, reducing urinary urgency and frequency. Common side effects include dry mouth and constipation.

Moleküler Ağırlık

325,5000 g/mol

LogP

5,60

TPSA

23,50 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Benign Prostatic Hyperplasia Pain Management Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1

InChI

InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1

Molecular Formula

C22H31NO

HBD / HBA

1 / 2

Döndürülebilir Bağlar

7

Ağır Atomlar

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication is used to treat overactive bladder, a condition characterized by frequent, urgent, and sometimes uncontrollable urination. It works by relaxing the bladder muscle by blocking muscarinic receptors, reducing urinary urgency and frequency. Common side effects include dry mouth and constipation.

Yes, Tolterodine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1382. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 443879. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Tolterodine PillFYI'da

Yapı

Hızlı Veriler

Formül: C22H31NO
Eş Anlamlılar: 4

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.